Chase Science Co., Ltd (SHE:300941)
23.52
+0.04 (0.17%)
At close: Feb 6, 2026
Chase Science Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 65.98 | 118.16 | 65.23 | 40.49 | 132.73 | 35.33 |
Short-Term Investments | - | 1,000 | 980 | 930.05 | 700.59 | - |
Trading Asset Securities | 336.28 | 21 | 123.13 | 255.72 | 324.22 | 385 |
Cash & Short-Term Investments | 402.26 | 1,139 | 1,168 | 1,226 | 1,158 | 420.33 |
Cash Growth | 491.06% | -2.50% | -4.72% | 5.94% | 175.39% | 50.39% |
Accounts Receivable | 128.29 | 64.16 | 77.77 | 89.25 | 74.58 | 100.03 |
Other Receivables | 36.13 | 112 | 83.02 | 16.92 | 13.02 | 2.16 |
Receivables | 164.42 | 176.16 | 160.79 | 106.17 | 87.6 | 102.19 |
Inventory | 125.55 | 30.62 | 13.47 | 22.69 | 17.41 | 42.05 |
Prepaid Expenses | - | 2.51 | - | - | - | - |
Other Current Assets | 664.84 | 6.3 | 10.91 | 0.81 | 1.45 | 4.7 |
Total Current Assets | 1,357 | 1,355 | 1,354 | 1,356 | 1,264 | 569.28 |
Property, Plant & Equipment | 3.26 | 4.48 | 6.29 | 5.79 | 7.12 | 2.36 |
Long-Term Investments | 4.14 | 4.14 | 7.73 | 15.14 | - | - |
Goodwill | 12.44 | 12.44 | - | - | - | - |
Other Intangible Assets | 0.27 | 0.37 | 0.26 | 0.4 | 0.3 | 0.37 |
Long-Term Deferred Tax Assets | 7.55 | 10.01 | 7.33 | 8.59 | 7.17 | 6.06 |
Long-Term Deferred Charges | 1.16 | 1.3 | 1.3 | 1.42 | 1.31 | 0.97 |
Other Long-Term Assets | 5.03 | 6.45 | 9.54 | 14.59 | 24.21 | - |
Total Assets | 1,391 | 1,394 | 1,386 | 1,402 | 1,304 | 579.04 |
Accounts Payable | 74.47 | 35.34 | 44.63 | 73.69 | 60.66 | 57.38 |
Accrued Expenses | 5.13 | 20.4 | 28.12 | 28.88 | 27 | 38.4 |
Short-Term Debt | - | 0.3 | - | - | - | - |
Current Portion of Leases | 1.74 | 2.04 | 3.05 | 2.46 | 3.21 | - |
Current Income Taxes Payable | 0.44 | 0.31 | 3.24 | 7.93 | 8.33 | 12.77 |
Current Unearned Revenue | 13.42 | 21.22 | 5.95 | 5.79 | 4.63 | 4.45 |
Other Current Liabilities | 9.29 | 12.18 | 6.69 | 5.05 | 3.98 | 3.38 |
Total Current Liabilities | 104.5 | 91.79 | 91.67 | 123.79 | 107.81 | 116.38 |
Long-Term Leases | 0.51 | 1.4 | 1.72 | 1.32 | 1.64 | - |
Long-Term Deferred Tax Liabilities | - | - | - | - | 0.03 | - |
Other Long-Term Liabilities | 10.12 | 13.61 | 15.2 | 16.63 | 13.76 | 13.5 |
Total Liabilities | 115.13 | 106.81 | 108.59 | 141.74 | 123.24 | 129.88 |
Common Stock | 204.75 | 204.75 | 204.75 | 204.75 | 136.5 | 102.38 |
Additional Paid-In Capital | 569.23 | 569.23 | 569.23 | 568.92 | 637.17 | 4.68 |
Retained Earnings | 546.02 | 556.47 | 533.33 | 486.31 | 407.19 | 342.11 |
Treasury Stock | -40.02 | -40.02 | -29.85 | - | - | - |
Comprehensive Income & Other | -3.34 | -3.34 | -0.91 | - | - | - |
Total Common Equity | 1,277 | 1,287 | 1,277 | 1,260 | 1,181 | 449.16 |
Minority Interest | -0.86 | 0.04 | 0.82 | 0.11 | - | - |
Shareholders' Equity | 1,276 | 1,287 | 1,277 | 1,260 | 1,181 | 449.16 |
Total Liabilities & Equity | 1,391 | 1,394 | 1,386 | 1,402 | 1,304 | 579.04 |
Total Debt | 2.25 | 3.74 | 4.76 | 3.78 | 4.86 | - |
Net Cash (Debt) | 400.01 | 1,135 | 1,164 | 1,222 | 1,153 | 420.33 |
Net Cash Growth | 543.49% | -2.42% | -4.82% | 6.05% | 174.23% | 50.39% |
Net Cash Per Share | 2.02 | 5.51 | 5.73 | 5.97 | 5.65 | 2.74 |
Filing Date Shares Outstanding | 202.96 | 202.96 | 203.39 | 204.75 | 204.75 | 153.56 |
Total Common Shares Outstanding | 202.96 | 202.96 | 203.39 | 204.75 | 204.75 | 153.56 |
Working Capital | 1,253 | 1,263 | 1,262 | 1,232 | 1,156 | 452.9 |
Book Value Per Share | 6.29 | 6.34 | 6.28 | 6.15 | 5.77 | 2.92 |
Tangible Book Value | 1,264 | 1,274 | 1,276 | 1,260 | 1,181 | 448.79 |
Tangible Book Value Per Share | 6.23 | 6.28 | 6.28 | 6.15 | 5.77 | 2.92 |
Machinery | - | 7.31 | 7.57 | 7.28 | 6.94 | 6.79 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.